Home Covid Boehringer Ingelheim makes record investment in R&D during pandemic

Boehringer Ingelheim makes record investment in R&D during pandemic

SHARE

The 2020 number is the highest annual investment in R&D in the pharma giant’s 136-year history.

This content is for Westfair Online members only. Please to view this content. Become a member by Registering Here.
Print Friendly, PDF & Email